ANXA3 and colonic neoplasm: Yang et al. employed the SERPA method to identify anti-maspin and anti-ANXA3 as potential biomarkers for colon cancer, demonstrating differential expression patterns in a limited cohort of eight patients with colon adenocarcinoma and liver metastasis at various stages [49].